The relevance of external quality assessment for molecular testing for ALK positive non-small cell lung cancer: results from two pilot rounds show room for optimization.

<h4>Background and purpose</h4>Molecular profiling should be performed on all advanced non-small cell lung cancer with non-squamous histology to allow treatment selection. Currently, this should include EGFR mutation testing and testing for ALK rearrangements. ROS1 is another emerging ta...

Full description

Bibliographic Details
Main Authors: Lien Tembuyser, Véronique Tack, Karen Zwaenepoel, Patrick Pauwels, Keith Miller, Lukas Bubendorf, Keith Kerr, Ed Schuuring, Erik Thunnissen, Elisabeth M C Dequeker
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0112159